Shenglong Q. Li

44, Xiaoheyna Rd, Dadong District, Liaoning 11042
Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Selection or Treatment? Interpreting EVT Benefit beyond 24 Hours in Basilar Artery Occlusion.

Selection or Treatment? Interpreting EVT Benefit beyond 24 Hours in Basilar Artery Occlusion.

Journal: Radiology

Published: August 18, 2026

Shiyiwei Shenqi Pian-derived quercetin reactivates apoptosis in clear cell renal cell carcinoma by destabilizing survivin and x-linked inhibitor of apoptosis protein.

Shiyiwei Shenqi Pian-derived quercetin reactivates apoptosis in clear cell renal cell carcinoma by destabilizing survivin and x-linked inhibitor of apoptosis protein.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 30, 2026

Treatment of Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.

Treatment of Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.

Journal: JAMA

Published: June 11, 2026

Integrated Engineering of CAR-T Cells for Solid Tumours.

Integrated Engineering of CAR-T Cells for Solid Tumours.

Journal: Cell proliferation

Published: April 03, 2026

Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441].

Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441].

Journal: Journal of bone oncology

Published: March 30, 2026

A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis.

A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis.

Journal: Molecular cancer

Published: March 28, 2026

Editorial: Research on nanomaterials in tumor diagnosis and therapy, volume II.

Editorial: Research on nanomaterials in tumor diagnosis and therapy, volume II.

Journal: Frontiers in bioengineering and biotechnology

Published: March 13, 2026

Neutrophil polarization landscapes in HCC: From immunosuppressive niches to antitumor immunity resuscitation.

Neutrophil polarization landscapes in HCC: From immunosuppressive niches to antitumor immunity resuscitation.

Journal: Cancer letters

Published: January 31, 2026

Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling.

Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling.

Journal: Cancer letters

Published: January 21, 2026

Recent advances in self-assembled nanoplatforms for central nervous system disorders therapy: Design principles, multifunctional strategies, and therapeutic applications.

Recent advances in self-assembled nanoplatforms for central nervous system disorders therapy: Design principles, multifunctional strategies, and therapeutic applications.

Journal: Materials today. Bio

Published: January 08, 2026

Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodeling.

Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodeling.

Journal: Journal of nanobiotechnology

Published: December 31, 2025

Prediction of PD-L1 expression in gastric cancer using 18F-FDG PET/CT radiomics.

Prediction of PD-L1 expression in gastric cancer using 18F-FDG PET/CT radiomics.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: December 22, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026